Cresha Lifesciences
Gliclazide (80mg) + Metformin (500mg)
Glycivas M 80mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet
Glycivas M 80mg/500mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glycivas M 80mg/500mg Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Glycivas M 80mg/500mg Tablet.
Glycivas M 80mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glycivas M 80mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Glycivas M 80mg/500mg Tablet is a combination of two antidiabetic medicines: Gliclazide and Metformin.
Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Glycivas M 80mg/500mg Tablet may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood. Monitor your blood sugar level regularly while you are taking this medicine.